Fundamental Analysis Report – TEVA PHARMACEUTICAL INDUSTRIES LTD. (TEVA)

In-depth Analysis Report – Teva Pharmaceutical Industries Ltd. (TASE: TEVA)
 A professional, comprehensive, and data-driven research report on Teva , the largest pharmaceutical company in Israel and a global leader in generic and specialty pharmaceuticals. The report presents an up-to-date financial picture, in-depth analysis of growth drivers, key profit channels, and an economic valuation for investors seeking informed investment decisions.
 What will you find in the report?
 ✔ Full analysis of financial performance: revenue, EBITDA, ROE, cash flow and liquidity ratios
 ✔ Sectoral segmentation: specialty drugs, generics, international markets, API activity and contract manufacturing
 ✔ Review of the corporate strategy – Pivot to Growth – and its impact on profitability
 ✔ Management, board of directors, ownership structure and institutional shareholders analysis
 ✔ Calculation of a 12-month target price combining DCF and EV/EBITDA models
 ✔ Sensitivity table with bullish, base and bearish scenarios
 ✔ Comparison against global competitors, multiples and pricing gap assessment
 The report was built specifically for Israeli investors who seek to understand Teva in depth – beyond the headlines, through the numbers.